Neutonic, the nootropics brand co-founded by James Smith and Chris Williamson, has recently raised $3.7M in funding at a valuation of $20M. This new capital will allow the company to expand its reach in the UK, US, and beyond.
Nootropics, also known as “smart drugs,” are a category of supplements and substances that are believed to enhance cognitive function, including memory, creativity, and focus. Neutonic’s products are based on natural ingredients and have gained popularity among consumers looking for a safe and effective way to boost their brainpower.
The company was founded in 2019 by two leading creators, Chris Williamson and James Smith, who were inspired by their own struggles with focus and productivity. With their combined expertise in marketing and supplement formulation, they set out to create a brand that would not only deliver results but also prioritize transparency and ethical sourcing.
Their dedication to quality and innovation has paid off, as Neutonic quickly gained a loyal following and became a top player in the nootropics market. The recent funding round, led by prominent investors, is a testament to the company’s success and potential for growth.
“We are thrilled to have the support of such experienced and visionary investors,” says James Smith, co-founder of Neutonic. “This funding will help us continue to develop cutting-edge products and reach even more customers who are seeking a safe and natural way to enhance their cognitive performance.”
Neutonic’s products are currently available through their online store and select retailers. With the new funding, the company plans to expand its distribution channels and launch in new markets, including the US. This move will not only increase accessibility for customers but also strengthen Neutonic’s presence as a global brand.
The success of Neutonic can be attributed to its unique approach to nootropics. Unlike many other brands that rely on synthetic ingredients and questionable marketing tactics, Neutonic places a strong emphasis on transparency and ethical sourcing. All of their products are made with natural, high-quality ingredients that are backed by scientific research.
Furthermore, the company prioritizes sustainability and ethical practices in all aspects of their business. They work closely with their suppliers to ensure fair wages and ethical sourcing of ingredients, and also donate a portion of their profits to support environmental causes.
“We believe that true success goes beyond just financial gains,” says Chris Williamson, co-founder of Neutonic. “We want to make a positive impact on people’s lives and the planet, and we are committed to doing so through our business practices and partnerships.”
Neutonic’s commitment to transparency, ethics, and sustainability has resonated with consumers, especially in the current climate where people are increasingly conscious of the impact of their purchases. This, combined with the company’s effective and natural products, has positioned Neutonic for continued success and growth.
With the new funding, Neutonic is set to become a major player in the global nootropics market. The company’s innovative approach and strong values make it a standout brand in a crowded industry. As more people seek natural and safe ways to enhance their cognitive function, Neutonic is well-positioned to meet this demand and make a positive impact on the world.
